What's breaking now, across thousands of outlets.
Announced mere weeks after Biohaven sold off rights to the therapy, opakalim, the halt affects a study some analysts believe is necessary to support a potential approval.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
"Significant financial challenges” facing the healthcare industry at large have limited Iowa Health Care’s ability to “responsibly” deploy capital toward the five-year build.
Getting a smartphone early in childhood may have lasting consequences. A new study links early phone ownership and social media access to worse psychological well-being, disrupted sleep, and strained…
Alzheimer’s disease is the most common form of dementia, but memory isn’t the only thing it affects The post Rethinking the Mechanisms of Alzheimer’s Disease appeared first on Nautilus .
The CMS released draft star ratings, including the thresholds for reaching those ratings, to plans earlier this week. The grading sheet got stricter, which doesn’t bode well for insurers, one MA…
The Food & Drugs Authority (FDA) has warned the public against the circulation of falsified Dr. Alfred Capsules, a dietary supplement marketed for male vitality on social media platforms. Read More...
[Nile Post] Africa's changing healthcare needs are creating new opportunities for generic medicine manufacturers to help close persistent access gaps, but stronger regional coordination, predictable…
